SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
52
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mattel, Inc. of Class Action Lawsuit and Upcoming Deadline – MAT

NEW YORK, April 07, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Mattel, Inc. (“Mattel” or the “Company”) (NASDAQ: MAT) and certain of its officers and directors.   The class action, filed in United States District Court, Central District of California, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who acquired Mattel securities between February 7, 2019, and February 15, 2019, inclusive (the “Class Period”), seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Mattel securities between February 7, 2019, and February 15, 2019, you have until May 6, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here to join this class action]

Mattel purports children’s entertainment company that designs and sells toys and consumer products. Mattel’s “Power Brands” include Barbie, Hot Wheels, Fisher-Price, and American Girl.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) demand for the Company’s products, including Barbie and Hot Wheels, was declining; (2) that the Company had an excess of product supply; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

On February 15, 2019, the Company provided disappointing outlook for 2019, citing slowing growth in sales of Barbie and Hot Wheels. On this news, the Company’s share price fell $3.09 per share, more than 18%, to close at $13.82 per share on February 15, 2019, on unusually high trading volume.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com .

CONTACT:

Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capacity LLC: Finalist in 2026 BeautyMatter Awards

Updated Category News Views 111

A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...

Continue Reading
Piramal Pharma FY27 Q2 Results: Robust Growth & Optimism

Updated Category News Views 38

A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
DICK'S Sporting Goods Faces Investor Lawsuit Deadline Looms

Updated Category News Views 23

A Rough Tumble for DICK'S Sporting Goods Let's cut to the chase: DICK'S Sporting Goods, Inc. (NYSE:DKS) just took a nosedive. We're talking a hard 30.68% fall on the stock, plummeting to $124.31 a share as of August 25, 2026. Now, if you were caught up in this whirlwind as an investor, you'd be forgiven for having a few choice words for the powers that be over at DICK'S....

Continue Reading
Political Jitters Push US Investors to Golden Visas

Updated Category News Views 118

Judging by the latest buzz from La Vida's 2026 survey, the golden ticket for many US investors isn't a hot stock but something far more unexpected: the coveted 'Golden Visa.' Out of over 5,000 wealthy individuals invited to participate, 94.3% are mulling over a second residency or citizenship, and the big trigger? Political concerns. It's a clear sign that plenty of...

Continue Reading
GeneDx Faces Scrutiny: Are Fiduciary Duties at Risk?

Updated Category News Views 71

What's Brewing at GeneDx? Looks like GeneDx Holdings Corp. is in some hot water—at least that's what Halper Sadeh LLC seems to think. Not your regular Tuesday at the exchange, folks. This legal eagle outfit is poking around GeneDx's henhouse, signaling possible breaches of fiduciary duties by their officers and directors. It's like catching a whiff of something fishy...

Continue Reading
BNY's Conference Spotlight: Strategic Moves Ahead?

Updated Category News Views 119

BNY's CFO to Unpack Strategies at BMO Financials Conference They say you can tell a lot about a company by the folks steering the ship. And let me tell you, folks, Dermot McDonogh from BNY is setting sail over to Boca Raton to spill some beans. November 9 marks the date when BNY’s Chief Financial Officer will stand behind the mic at the BMO Financials Conference at 8:45...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 9

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
Jennifer Sharp Bolsters Signature Wealth's Greenville Team

Updated Category News Views 88

New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 7

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading

Top 5 Most Recently Viewed Articles

Nutriband Inc.'s Highlight at 2024 Noble Conference in Boca Raton

Updated Category News Views 96

Nutriband Inc. to Showcase Innovations at Noble Conference Nutriband Inc. is set to make a significant impact at the upcoming Noble Conference, which takes place at Florida Atlantic University. The event is scheduled for early December, where the company will highlight its advancements in transdermal pharmaceutical products. Key Presentation Details At the Noble...

Continue Reading
ADT Inc. Plans Significant Financial Results Announcement

Updated Category News Views 123

ADT Inc.'s Financial Results Release ADT Inc. is preparing to unveil its second quarter financial results soon. While the specific date of this event is not mentioned here, it’s highly anticipated within the financial community. Prior to the market opening, ADT will share details on its performance at this key time for the company. Conference Call and Webcast Details...

Continue Reading
ProcessUnity's Vision for Transforming Risk Management by 2025

Updated Category News Views 594

Transforming Third-Party Risk Management: ProcessUnity's Ambitious Goals As an industry leader in third-party risk management, ProcessUnity has made significant strides over the past year, showcasing impressive growth and innovation. With a firm commitment to addressing modern security challenges, the company plans to revolutionize the TPRM landscape in 2025. This...

Continue Reading
Harnessing AI for Materials Discovery Amid Computing Challenges

Updated Category News Views 125

AI's Impact on Materials Discovery In today's swiftly evolving technological landscape, advancements in AI are making a significant impact on various fields, particularly in materials science. The integration of AI in materials research aims to accelerate the discovery process and improve efficiency, enabling researchers to bring innovative solutions to the forefront....

Continue Reading
Exploring the Growth and Impact of IVR Software Solutions

Updated Category News Views 123

Overview of Interactive Voice Response (IVR) Software Market The Global Interactive Voice Response (IVR) Software market is anticipated to witness significant growth in the coming years. Projections indicate an increase from USD 4,596.5 million in the near future to USD 6,124.6 million by the end of the forecast period, reflecting an impressive Compound Annual Growth Rate...

Continue Reading